Some studies have tied paraquat to Parkinson's disease and other serious health risks, but the EPA determined in 2019 that ...
Over the years, many celebrities have opened up about dealing with their cancer diagnosis. From Mamta Mohandas to Hamsa ...
Incyte Japan Announces Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for Adults with Relapsed or ...
Incyte (INCY) stock dropped 0.78% to $98.22 as Japan approved Minjuvi for relapsed DLBCL treatment, marking the drug's second ...
Former Brazil coach Carlos Alberto Parreira was admitted to the Samaritano hospital in Rio de Janeiro, the clinic said in a statement on Wednesday without giving further details. Parreira was ...
Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59% reduction in risk of disease progression or death1 People with relapsed ...
We have curated a list of in vivo CAR T biotech companies in preclinical and clinical stages that you should keep an eye out ...
CAR T-cell therapy genetically alters a patient's immune cells to fight certain cancers like lymphoma and leukemia.
FDA accepts sBLA for Roche’s combination drug to treat relapsed LBCL: Basel, Switzerland Friday, June 19, 2026, 11:00 Hrs [IST] Roche announced that the US Food and Drug Adminis ...
Australian patients risk losing access to lifesaving medicines, with the nation “cleaved off” from global drug development, ...
A recent study has found that people who are obese or have a higher Body Mass Index BMI are at risk of 19 cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results